Schedule 13D ownership disclosure
DIANTHUS THERAPEUTICS INC COM
Security class unavailable · CUSIP: 55910K108
Event date: 2021-02-11
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 31,483,991
- Percent of class
- 6.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001387131-21-002579
- Form type
- SC 13D
- Filer
- Atlas Venture Fund X, L.P.
- CIK
- CIK 1628098
- Filed
- Feb 17, 2021
- Reporting period
- Feb 11, 2021
- Description
- Schedule 13D beneficial ownership